FYN and Alzheimer disease: miR-106b whose expression is reduced in AD tissue, directly binds to the 3′UTR of Fyn mRNA, and consequently deregulates Fyn mRNA expression resulting in decreased Fyn mRNA levels mostly in the frontal cortex.